{"id":337681,"date":"2025-08-23T03:46:39","date_gmt":"2025-08-23T03:46:39","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/337681\/"},"modified":"2025-08-23T03:46:39","modified_gmt":"2025-08-23T03:46:39","slug":"pres-de-rouen-lusine-aspen-fragilisee-par-la-baisse-de-la-demande","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/337681\/","title":{"rendered":"Pr\u00e8s de Rouen, l\u2019usine Aspen fragilis\u00e9e par la baisse de la demande"},"content":{"rendered":"<p>L\u2019annonce est tomb\u00e9e en plein \u00e9t\u00e9, lors d\u2019un comit\u00e9 social et \u00e9conomique. La direction a confirm\u00e9 son intention d\u2019all\u00e9ger les effectifs d\u2019environ un quart. Pr\u00e8s de 200 postes devraient dispara\u00eetre, principalement par ruptures conventionnelles et non-renouvellements de contrats pr\u00e9caires. L\u2019usine emploie plus de 800 personnes dont une majorit\u00e9 travaille \u00e0 la production de la Fraxiparine, un anticoagulant \u00e0 base d\u2019h\u00e9parine de bas poids mol\u00e9culaire. Ce traitement souffre d\u00e9sormais d\u2019un net recul de la demande. \u00c0 cela s\u2019ajoute la perte d\u2019un client majeur qui fragilise encore davantage l\u2019\u00e9quilibre \u00e9conomique du site. <\/p>\n<p>Un \u00e9tablissement embl\u00e9matique en difficult\u00e9<\/p>\n<p>D\u2019abord propri\u00e9t\u00e9 des laboratoires Choay, puis int\u00e9gr\u00e9 \u00e0 Sanofi et \u00e0 Glaxo SmithKline, ce site rouennais est pass\u00e9 en 2014 sous le contr\u00f4le d\u2019Aspen. Pendant des d\u00e9cennies, il a fait travailler des g\u00e9n\u00e9rations d\u2019ouvriers et de techniciens dans l\u2019agglom\u00e9ration rouennaise. Ces derni\u00e8res ann\u00e9es, l\u2019usine avait tent\u00e9 de r\u00e9duire sa d\u00e9pendance aux anticoagulants en misant sur la fabrication d\u2019anesth\u00e9siques et de produits injectables sous conditions st\u00e9riles. Toutefois, ces efforts semblent insuffisants pour maintenir l\u2019effectif actuel. <\/p>\n","protected":false},"excerpt":{"rendered":"L\u2019annonce est tomb\u00e9e en plein \u00e9t\u00e9, lors d\u2019un comit\u00e9 social et \u00e9conomique. La direction a confirm\u00e9 son intention&hellip;\n","protected":false},"author":2,"featured_media":337682,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9587],"tags":[1111,11,1777,674,1011,27,12,5161,25,9590],"class_list":{"0":"post-337681","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-rouen","8":"tag-actu","9":"tag-actualites","10":"tag-eu","11":"tag-europe","12":"tag-fr","13":"tag-france","14":"tag-news","15":"tag-normandie","16":"tag-republique-francaise","17":"tag-rouen"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115076030974406694","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/337681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=337681"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/337681\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/337682"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=337681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=337681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=337681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}